There are two layers of evidence here: the date filter for the financing list is set to 2025; project-associated reports span multiple historical years and may not cover the current round of financing for the project. The former is used to describe the existing list, while the latter is used to understand business mechanisms; the two cannot be mixed into the same annual sample.
What this batch of materials can answer
| Materials | Current coverage | Usage boundaries |
|---|---|---|
| Financing list | 2973 entries, 2514 distinct projectIds | This is the number of records, not the number of full texts, nor the number of market-wide transactions |
| Project summaries | 42 documents | Indexes/summaries only; cannot serve as full-text project research |
| Associated article paths | 135 paths | 39 of these news flashes are empty shells |
| Articles with full text | 96 paths, 95 unique full texts | The same article appears once across directories; 42 articles already have archives, 53 are newly added unique full texts |
| Full-text digestion for this round | 95 unique Markdown files: 53 newly added, 42 re-read from old archives | With per-article digests; only existing Markdown files were fully read. Tables inside images and external links are not counted in full-text coverage |
The total target count reported by crawl metadata is 3002; the existing list is 29 entries short. This is only a quantity difference, and it is not possible to know which 29 entries are missing. Among the 2514 project links in the INDEX, only 42 have actual summaries; the remaining 2472 links cannot be treated as having obtained details. The number of lines in the failure log includes retries and cannot replace the count of independently failed projects. List (local reference material) · Original index (local reference material)
Recalculable profile of the 2025 list
Counted by financingDate Asia/Shanghai dates, all 2973 entries fall in 2025. The following counts only existing records; closing was not reconfirmed against report texts, and different entities of the same transaction were not additionally merged.
| Month | Number of entries | Month | Number of entries |
|---|---|---|---|
| January | 106 | July | 240 |
| February | 163 | August | 280 |
| March | 276 | September | 278 |
| April | 221 | October | 232 |
| May | 245 | November | 252 |
| June | 292 | December | 388 |
December has the most records, but without crawl coverage verification and actual transaction time validation, this cannot be attributed to a sudden easing of capital. The dates of news release, industrial and commercial registration changes, and actual closing may also differ.
| Industry tag | Occurrences | Industry tag | Occurrences |
|---|---|---|---|
| Advanced manufacturing | 860 | Healthcare | 545 |
| Frontier technology | 437 | Enterprise services | 281 |
| Traditional manufacturing | 210 | Smart hardware | 186 |
| Automotive and mobility | 155 | Telecommunications/semiconductors | 132 |
| Industrial upgrading | 112 | Consumer e-commerce | 95 |
Industries are multi-select tags, so the same record may be counted under multiple categories. Therefore, the sum of the top three categories cannot be called the share of independent transactions, much less the share of capital absorbed.
The most common values in the original round field are Series A with 380, Series B with 344, equity financing with 328, Series A+ with 206, M&A/merger with 193, strategic financing with 157, Series C with 153, Series B+ with 152, IPO with 131, and private placement with 130. There are empty round values and anomalous values such as 1; this page retains the original classification and does not force unknown values into early-stage rounds.
In the amount field, 1414 entries state "undisclosed"; the remaining 1559 entries are not all precise figures, and include fuzzy ranges such as "tens of millions" and different currencies. Total financing amount is not calculated here, and fund size, enterprise valuation, or registered capital are not treated as financing amounts. Raw statistics data (local reference material)
How material breakthroughs become products customers can buy
A 2023 solid-state battery report noted that a drop in laboratory material prices does not mean the cost of the entire battery falls in lockstep: positive and negative electrodes remain major cost items, while production line speed, yield, and solid contact interfaces introduce additional constraints. The production speed gap cited in the article is from an interviewed case, not a uniform metric for all factories. For product leaders, the key is to ask separately: "Has sample performance improved?" and "Has stable mass delivery at target cost been achieved?" Commercialization threshold (local reference material)
Tailan's 2025 "Cold Core" product adjusted heat dissipation channels, bottom liquid cooling, cathode coating, graphite structure, ring welding, and scroll reinforcement together. Its mechanism is that materials, structure, and process simultaneously reduce thermal and transmission barriers, while modularization reduces retooling work; 6C and 9-minute charging are release claims, and no independent real-world testing or customer-scale delivery data for this round is provided. Good-looking technical specifications still require verification of lifespan, safety, manufacturing consistency, and cost. Product release (local reference material)
Two 2023 reports on Tuoxene provide clearer layers of progress: in July, a nearly RMB 1 billion Series B round and factory construction; in November, a RMB 100 million strategic financing round and the mass production and shipment of 3,000 tons of SOOC in phase one, with supply to first-batch customers. The latter is closer to customer value than "construction completed," but without full-year actual sales and profits, nominal capacity cannot be treated as sales. Properties such as transparency, heat resistance, barrier performance, and low extractables must all meet optical or packaging use requirements, and customer validation is also part of commercialization. July (local reference material) · November (local reference material)
A counterexample is a large-financing roundup in the same batch that describes Tuoxene as a graphene film enterprise, which clearly conflicts with the polymer business described in the original exclusive interview. This product description is not adopted here, nor is its evidence level raised simply because the title includes "large financing." Source conflict (local reference material)
A 2024 report on Beike Yunhong's low-carbon cementitious materials links the compounding of industrial solid waste ingredients, mixed grinding, and non-firing processes. The four disclosed production lines and stable capacity are recorded separately from the planned capacity for the following year. The cost and emission reduction advantages claimed by the company still require project-level verification; especially when carbon trading methodologies are still being formulated, potential carbon revenue cannot be counted as existing profit. Basic sales economics and additional policy income must be measured separately. Case (local reference material)
How one technology base generates multiple products
In 2022, UnionXinan expanded from quality testing to static analysis, security testing, and digital circuit verification, based on shared compilation, program analysis, and formalization technologies. This expansion has a clear reuse relationship, rather than opening new businesses whenever a new track is spotted. The company claims to shorten customer testing cycles, but there are no independent controlled experiments in this batch; false positive rates, coverage, domestic environment adaptation, and customer delivery costs should continue to be monitored. Case (local reference material)
Zhangba Cybersecurity's cyber range trains technical personnel, while its decision sandbox allows managers to deduce consequences. In the 2024 report, virtualization and digital modeling make trade-offs between fine-grained restoration and large-scale simulation, and combinable scenario applications on the platform reduce per-customer rewrites. Whether costs are truly reduced depends on scenario reuse rates and delivery cycles; investor claims of above-expected growth cannot substitute for revenue or profit evidence. Series B and product mechanism (local reference material)
Chenxin's 2024 testing equipment case illustrates that high-speed chip switching imposes new anti-interference requirements on measurement tools. It uses its self-developed source meters both as core components and as standalone products for sale, covering multiple testing stages from wafer to system. Over 200 units shipped and first overseas installations are the landing evidence claimed in the text; CT high-voltage generators are still in the introduction phase, and one mature product line cannot prove mass production for another. Case (local reference material)
High-end services, healthcare, and robotics: growth metrics must correspond to customer value
Materials on Yao Chuxing from 2020–2023 frame transportation services as a high-end concierge experience: vehicles, professional chauffeurs, scheduled pickups and drop-offs, bilingual service, privacy, and butler service form the complete delivery. Drivers and service standards affect customer experience but also increase operational complexity. Labels such as "quasi-unicorn," registered users, or advertised monthly growth rates, without profit, payment rates, or complete base periods, cannot be treated as evidence of scalable profitability. 2022 archive (local reference material) · 2023 interview (local reference material)
A 2022 report on medical robots provides the opposite example: while financing announcements remain hot, hospital procurement and clinical trials may be delayed. To get through engineering prototypes, clinical validation, market access, procurement budgets, and payment chains, financing only resolves the capital constraint among them. Keenon's reuse of its mobility capability for medical delivery is not the same threshold as developing surgical instruments; "serving hospitals" cannot be treated as a unified market. Commercialization counterexample (local reference material)
Clinical Phase III, planned enrollment, preparation for overseas trials, and commercialization negotiations in Pulai's 2022 interview are all different milestones and cannot be rewritten as the drug having been approved or its efficacy proven. A 2023 article on AI pharma further distinguishes between selling software, selling R&D services, and self-developed drugs: revenue models and development risks borne differ, and obtaining algorithm financing does not equal obtaining drug approval. Pulai (local reference material) · AI pharma (local reference material)
How money, industrial resources, and organizational capability coordinate
In a 2022 article on the Social Security Fund, LPs are fund contributors, and GPs are institutions responsible for selecting and managing projects. Capital may pass through funds of funds before reaching enterprises; the RMB 50 billion fund size is not the Social Security Fund's contribution in that instance, much less the financing amount of a particular portfolio company. Long-term capital is suited to waiting for manufacturing R&D, production lines, and customer validation, but does not guarantee any project will profit. Team stability and governance also affect whether capital continues to be invested. Mechanism and amount boundaries (local reference material)
Reports on Xuzhou's semiconductor and Hangzhou's venture capital ecosystems respectively demonstrate industrial clustering, local funds, and venture capital networks. Regional industrial customers, professional talent, early-stage capital, and follow-on financing form different support links; the existence of funds or signing ceremonies only indicates resources are present, and whether they reduce project validation and sales costs still requires operational data. Xuzhou (local reference material) · Hangzhou (local reference material)
Materials on Hummingbird pilot-scale services and Qinchuangyuan signings remind that between scientific research outcomes and factories there is still engineering validation and small-batch trial production; forums and incubators can connect resources but cannot replace pilot-scale testing. Yuanhe's learning organization article emphasizes experience review and organizational accumulation, which is suitable for supplementing "how to improve judgment and execution after obtaining capital," and cannot be recorded as a financing event. Hummingbird (local reference material) · Signing (local reference material) · Organization (local reference material)
2025 customer service case: how memory systems connect delivery and revenue
An August 2025 report on Red Bear provides a concrete product path: connecting enterprise knowledge, historical tickets, and context across channels such as phone, App, and mini-programs, so that users do not have to describe their problem from scratch when switching channels. When a customer service Agent encounters a difficult problem and transfers to a human agent, it can later transfer back to the Agent; the key of the mechanism is whether handover materials and processing status can be retained, not just adding a chat entry. The coexistence of standard SaaS, private deployment, and model services indicates that different customer requirements for deployment and customization still affect delivery costs. August case (local reference material)
By December, the report used working memory, long-term knowledge graphs, and cognitive episodic memory to describe multi-turn context and experience invocation. These are product architectures and analogies, and cannot be used to assert that it possesses human-like memory. The year-end cross-modal release and chip roadmap still contain future plans and should be recorded separately from already published open-source projects. December case (local reference material)
This case is especially suitable for practicing amount caliber: the August Pre-A amount was not disclosed, and RMB 500 million was the post-money valuation; the December Pre-A+ financing amount was RMB 80 million, with a post-money valuation of RMB 750 million. The year-end report lists contract value of RMB 250 million and recognized revenue of RMB 135 million, which are not the same metric. Early revenue targets and year-end caliber also changed, so report dates must be retained. Self-service resolution rates, accuracy rates, and cost-reduction ratios in customer cases are single-item evidence provided by the company, lacking a unified denominator and independent controls, and cannot directly serve as the compliance line for all customer service products.
2020–2023 supplementary cases: hardware, access, and industrial supporting facilities
Qingting Acoustics' 2021 and 2023 materials connect screen sound generation, directional sound, and privacy needs. Algorithms, materials, and manufacturing processes jointly determine delivery, while technology licensing, OEM cooperation, and own brands correspond to different operating models. Statements about releases, cooperation, or mass production in reports do not automatically indicate sustained sales and profitability. A 2023 article on the AR supply chain further demonstrates the trade-offs among appearance, performance, and cost: design-manufacturing collaboration can shorten iterations, but large customers moving upstream may also change supplier bargaining power. Therefore, the questions to ask should be about verified orders, yield, and customer concentration, not just financing valuations. Qingting 2021 (local reference material) · Qingting 2023 (local reference material) · AR supply chain (local reference material)
Reports on surgical robots from 2020 to 2023 should be strung into the chain of “R&D — clinical trials — approved indications — hospital procurement — actual use and payment”. Approval for a certain indication does not mean the robot can be used for all surgeries; installation for research purposes and installation for training are also different from regular paid services. Quotation comparisons must also unify device configurations, services, and consumables. The term “domestic” in articles may involve ownership, R&D, or local manufacturing, and should not be directly treated as the same concept. Some comments contain inconsistent calibers or subjects; retaining doubts is more reliable than patching together a definitive development history. Jingfeng in its early stage (local reference materials) · Financing signing (local reference materials) · Procurement and pricing (local reference materials) · Foreign-funded devices (local reference materials)
The 2021 materials on nucleic acid drugs are industry explanations rather than financing cases: after sequence design, issues such as stability, tissue delivery, cell entry, and side effects still need to be resolved. Advances in platform technology do not mean that every drug is already safe and effective, nor does the number of clinical projects equal the number of marketed drugs. Delivery and R&D thresholds (local reference materials)
Local funds and incubation services: turning “having resources” into “what costs are reduced”
In the 2022 urban incubation cases, practices such as Changyuan, Kanazawa, Baden-Württemberg, and CONNECT have different roles: traditional industries need to connect to new supply chains; growing enterprises may need shared testing, training, and factory space; scientific research entrepreneurs also need business talents and customer networks. Bottlenecks should be identified according to the stage the enterprise is in, and all enterprises cannot be placed into the same incubation template. The cases illustrate possible mechanisms of action, but do not prove a causal relationship between resource allocation and growth. Service mechanisms of different cities (local reference materials)
The 2020 fund reports and the 2023 Panlin Chengdu case also remind that local industrial landing and financial returns may simultaneously become funding objectives. DPI focuses on cash already returned to investors, while book valuations or IRR alone cannot prove cash recovery. Concentration in early-stage investment, continuous follow-on investment, and post-investment industrial support each bring opportunities and capital occupation risks, which need to be evaluated separately. Fund mechanisms (local reference materials) · Chengdu case (local reference materials)
2026 related reports listed separately: model business and task costs
Articles related to Moonshot AI, MiniMax, and Token pricing are 2026 related materials and are not included in the 2025 financing statistics above. For product owners, a more reusable question is: how many inputs, outputs, caching, retries, and manual corrections are used to complete a task. A decline in the unit price of Tokens may be accompanied by an increase in usage per task; an API price increase also does not mean that a pay-for-results contract has been signed. Pricing discussions (local reference materials) · Commercial path comments (local reference materials)
Long-task engineering also involves gateways, routing, state preservation, failure recovery, and traceable records. Single code demonstrations and benchmark scores cannot replace the success rate and cost of actual customer tasks. Future product specifications, financing under negotiation, and listing rumors in the text should all retain their predictive nature; sufficient funds also cannot directly lead to the conclusion of profitability or a valid business model. K2.6 engineering (local reference materials) · Financing and revenue calibers (local reference materials)
ARR is an annualized value of revenue converted at the current rate, which is different from confirmed annual revenue. Valuation divided by ARR only yields the run-rate multiple at that point in time. Some revenue aggregation calibers in MiniMax-related articles, as well as the certainty in Moonshot AI listing headlines and the main text, are not fully consistent and cannot be filled in on one’s own. Although recruitment summaries, stock market evening reports, and share reduction comments have been read in full, they are mainly used as background and evidence boundary cases, and are not packaged as new financing for related projects. MiniMax caliber records (local reference materials) · Listing report boundaries (local reference materials)
When using these materials, retain four verification actions
- Verify the subject. Huahuixin financing appears in the Huaxing Laser catalog due to investment relationships; Fa'ao Yiwei financing appears in the Shurui catalog. Catalog associations cannot replace the subject in the main text.
- Verify the stage. Signing of intent, announcement of financing, industrial and commercial changes, closing, listing tutoring, and completion of listing are recorded separately; projected revenue is separated from realized revenue.
- Verify the event. The next-day morning report on Zhangba’s Series A, and the morning report and weekly report on Tuoxene’s Series B are duplicate reports; distinguish them from later new rounds. Multiple appearances of the same news do not mean multiple funds.
- Verify the time and statistical population. The 2020–2024 weekly reports can explain cases but do not support the 2025 industry growth rate; multi-industry summaries, fund fundraising, corporate financing, and global data also cannot be directly added together.
The cases on this page are used to form questions that can be followed up, and do not represent proven investment advice or current operating status. All judgments are limited to the scope of the listed historical reports.